You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Strides Pharma Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for STRIDES PHARMA, and what generic and branded alternatives to STRIDES PHARMA drugs are available?

STRIDES PHARMA has two hundred and sixty approved drugs.

There are three tentative approvals on STRIDES PHARMA drugs.

Summary for Strides Pharma

US Patents:	0
Tradenames:	157
Ingredients:	153
NDAs:	260
Patent Litigation for Strides Pharma:	See patent lawsuits for Strides Pharma

Drugs and US Patents for Strides Pharma

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Strides Pharma	FLUOXETINE HYDROCHLORIDE	fluoxetine hydrochloride	TABLET;ORAL	212683-001	Sep 13, 2024	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Strides Pharma	TOPIRAMATE	topiramate	CAPSULE;ORAL	078418-001	Oct 14, 2009	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Strides Pharma	TESTOSTERONE	testosterone	GEL;TRANSDERMAL	076744-002	May 23, 2007	AB1	RX	No	No		⤷ Sign Up				⤷ Sign Up
Strides Pharma	ATORVASTATIN CALCIUM	atorvastatin calcium	TABLET;ORAL	217634-001	Dec 21, 2023		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Strides Pharma	CINACALCET HYDROCHLORIDE	cinacalcet hydrochloride	TABLET;ORAL	209226-001	Apr 30, 2018	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Strides Pharma

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Strides Pharma	ACCOLATE	zafirlukast	TABLET;ORAL	020547-001	Sep 26, 1996	6,143,775	⤷ Sign Up
Strides Pharma	ACCOLATE	zafirlukast	TABLET;ORAL	020547-001	Sep 26, 1996	5,482,963	⤷ Sign Up
Strides Pharma	ACCOLATE	zafirlukast	TABLET;ORAL	020547-001	Sep 26, 1996	5,319,097	⤷ Sign Up
Strides Pharma	VEPESID	etoposide	CAPSULE;ORAL	019557-001	Dec 30, 1986	3,524,844	⤷ Sign Up
Strides Pharma	CAPOTEN	captopril	TABLET;ORAL	018343-007	Jun 13, 1995	4,215,104	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for STRIDES PHARMA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	10 mg and 20 mg	➤ Subscribe	2008-02-29
➤ Subscribe	Delayed-release Tablets	20 mg	➤ Subscribe	2015-06-03

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Strides Pharma

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.